Medifast (MED) FCF Margin (2010 - 2026)

Medifast's FCF Margin history runs 17 years deep, the most recent figure standing at 1.1% for Q1 2026.

• Quarterly FCF Margin fell 273.0% year-over-year to 1.1% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.43% (down 290.0% YoY) and the FY2025 annual result came in at 0.32%, down 250.0% from the prior year.
• FCF Margin was 1.1% for Q1 2026 at Medifast, up from 8.83% in the prior quarter.
• Across five years, FCF Margin topped out at 17.75% in Q1 2023 and bottomed at 8.83% in Q4 2025.
• A 5-year average of 6.01% and a median of 6.6% in 2024 frame the typical range for FCF Margin.
• Annual changes were most pronounced in 2022 — FCF Margin surged 1770 bps — and 2024, when it sank 1464 bps.
• Medifast's FCF Margin stood at 12.65% in 2022, then plunged by 60 bps to 5.01% in 2023, then plunged by 221 bps to 6.08% in 2024, then slumped by 45 bps to 8.83% in 2025, then jumped by 88 bps to 1.1% in 2026.
• Business Quant data shows MED's FCF Margin at 1.1% in Q1 2026, 8.83% in Q4 2025, and 12.02% in Q3 2025.